12/15/2020 Update
Colorado has published a 3 phase distribution plan:
11/24/2020 With the possibility of one or more COVID-19 vaccines becoming available before the end of the year, here are several things you need to know:
1. There may be a limited supply of COVID-19 vaccines before the end of 2020, but supply will continually increase in the weeks and months that follow. If there is limited supply, some different risk groups may be recommended to get a COVID-19 vaccine first.
2. Experts are working on how to distribute these limited vaccines in a fair, ethical, and
transparent way. We plan to follow CDC and national guidelines once these are available. We will reach out to our patients as soon as we are
notified about vaccine availability and distribution.
3. CDC is working with partners at all levels, including healthcare associations, on flexible COVID-19 vaccination programs that can accommodate different vaccines and scenarios.
4. We understand that some people may be concerned about getting vaccinated once a COVID-19 vaccine is available in the United States. While these vaccines are being developed as quickly as possible, routine processes and procedures remain in place to ensure the safety of any vaccine that is authorized or approved for use. Safety is a top priority, and there are many reasons to get vaccinated.
5. COVID-19 vaccines are being carefully evaluated in clinical trials and will be authorized or approved only if they make it substantially less likely you’ll get COVID-19.
6. Based on what we know about vaccines for other diseases, experts believe that getting a COVID-19 vaccine may help keep you from getting seriously ill even if you do get COVID-19.
7. Vaccines purchased with U.S. taxpayer dollars will be given to the American people at no cost.
However, providers who administer vaccines
will be able to charge administration fees for
giving or administering the shot to someone. Vaccine providers can get this fee reimbursed by the patient’s public or private insurance company or, for uninsured patients, by the Health Resources and Services Administration’s Provider Relief Fund.
Comments